The following is a list of companies whose shares may have unusual price changes in Zurich. Stock symbols are in parentheses and share prices are from the last close.
ABB Ltd. (ABBN VX): The company agreed to buy Louisiana- based K-TEK for an undisclosed sum. K-TEK, which will join the measurement products business unit within ABB’s process automation division, has annual sales of about $50 million and employs more than 250 people with operations in China, the Netherlands, India and South Africa in addition to the U.S., according to an e-mailed statement. The shares rose 0.7 percent to 19.83 francs.
APEN AG (APEN SW): Christian Wenger has revoked his intention to step down from Apen Ltd.’s board and will stand for re-election at the June 7 annual shareholders meeting, the Swiss investment company said in an e-mailed statement. The shares lost 0.9 percent to 16.75 francs.
Meyer Burger Technology AG (MBTN SW): The maker of industrial cutting equipment won an order worth more than 25 million Swiss francs ($21.7 million) with a new customer in China. The shares gained 1 percent to 25.3 francs.
Mindset Holding AG (MIND SW): The electric sports car designer will increase its capital by selling 200,000 shares. Mindset dropped 2.7 percent to 3.6 francs.
Novartis AG (NOVN VX): The drugmaker’s Tasigna medicine was more effective at treating newly diagnosed leukemia than the company’s best-selling Gleevec drug.
Tasigna cut levels of a protein linked to chronic myeloid leukemia in three times as many patients as in those taking Gleevec after 18 months, the Basel, Switzerland-based company said today. The shares rose 1 percent to 53.35 francs.
Partners Group Holding AG (PGHN SW): The Swiss money manager which is focused on private equity investments had its price estimate lifted to 147 francs from 121 francs at Credit Suisse Group AG. The brokerage kept a “neutral” rating. The shares ended unchanged at 133.7 francs.
Roche Holding AG (ROG VX): UBS AG added the world’s biggest maker of cancer medicines to its “most preferred” stocks in the European pharmaceutical industry. The shares advanced 1.1 percent to 164.7 francs.